Alamar Biosciences Inc.
ALMR | NASDAQ
$28.96
-$1.64 (-5.36%)
Nov 2, 2026, 2:53 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 |
|---|---|---|
Cash & Equivalents | 30M | 26.77M |
Short-Term Investments | n/a | 52.59M |
Long-Term Investments | n/a | n/a |
Other Long-Term Assets | 6.67M | 5.67M |
Receivables | 12.75M | 7.32M |
Inventory | 38.48M | 14.41M |
Other Current Assets | 13.47M | 5.61M |
Total Current Assets | 94.71M | 106.7M |
Property-Plant & Equipment | 36.63M | 35.1M |
Goodwill & Intangibles | 1.99M | 2.04M |
Total Long-Term Assets | 45.29M | 42.81M |
Total Assets | 139.99M | 149.51M |
Account Payables | 5.87M | 6.19M |
Deferred Revenue | 470K | 575K |
Short-Term Debt | n/a | n/a |
Other Current Liabilities | 7.59M | 5.42M |
Total Current Liabilities | 23.73M | 16.59M |
Long-Term Debt | 9.81M | n/a |
Other Long-Term Liabilities | 235.84M | 235.14M |
Total Long-Term Liabilities | 275.22M | 266.33M |
Total Liabilities | 298.95M | 282.92M |
Total Debt | 41.47M | 33.1M |
Book Value | -158.95M | n/a |
Book Value Per Share | -2.39 | n/a |
Common Stock | 1K | 1K |
Retained Earnings | -168.78M | -138.96M |
Comprehensive Income | -72K | 149K |
Shareholders Equity | -158.95M | -133.41M |
Total Investments | n/a | 52.59M |
Add to Watchlist
Select watchlists to add or remove ALMR